Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03582605 · ClinicalTrials.gov registry record · Early Phase 1
Antibiotics Prior to Mini-screw Implant Insertion
A Early Phase 1 study, sponsored by St. Louis University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 31
- Enrollment target
NCT03582605 is a Early Phase 1 study that has completed, run by St. Louis University. The registered enrollment target is 31 participants.
The verdict
NCT03582605, a Early Phase 1 study, has completed, sponsored by St. Louis University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 31 participants
- Enrollment target
Study Summary
The investigators plan to use amoxicillin in capsule form, prepared by a pharmacist, for antibiotic prophylaxis to decrease the failure rate of mini-screw implants temporarily placed in the palate of patients involved in Phase II orthodontics treatments. The mini-screws will be 8 mm long 1.7 mm diameter titanium screws manufactured by Forestadent and are commercially available and currently widely used in orthodontic treatment in both private practice and educational settings. Since antibiotic prophylaxis is considered the standard of care with traditional dental implants, the investigators believe that such prophylaxis will decrease the failure rate of orthodontic mini-screw implants also.
Interventions
- DRUG Placebo oral capsule
- DRUG Amoxicillin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2018-08-07 |
| Est. Completion | 2020-11-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03582605
The ClinicalTrials.gov registry entry for NCT03582605 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Louis University, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo oral capsule is the first listed.
NCT03582605 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03582605 about?
NCT03582605 is a clinical study titled "Antibiotics Prior to Mini-screw Implant Insertion". The investigators plan to use amoxicillin in capsule form, prepared by a pharmacist, for antibiotic prophylaxis to decrease the failure rate of mini-screw implants temporarily placed in the palate of patients involved in Phase II orthodontics treatments. The mini-screws will be 8 mm long 1.7 mm diam...
What is the current status of trial NCT03582605?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 31 participants. The study started on 2018-08-07. Estimated completion is 2020-11-01.
What interventions are being tested in trial NCT03582605?
The interventions under investigation include: Placebo oral capsule (DRUG), Amoxicillin (DRUG).
Who is sponsoring clinical trial NCT03582605?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.